Interleukin 35 ELISA Kit

Produktnummer ABIN6574300

Produktdetails Interleukin 35 ELISA Kit

Target: Interleukin 35 (IL35)

Reaktivität: Human

Nachweismethode: Colorimetric

Methodentyp: Sandwich ELISA

Detektionsbereich: 15.6 pg/mL - 1000 pg/mL

Untere Nachweisgrenze: 15.6 pg/mL

Applikation: ELISA

Verwendungszweck: The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of IL35 in human serum, plasma, tissue homogenates, cell lysates, cell culture supernates.

We offer validation data (WB) for the kit components. So you can be sure to order a reliable ELISA kit product composed of high quality reagents.

Proben: Cell Culture Supernatant, Cell Lysate, Plasma, Serum, Tissue Homogenate

Analytische Methode: Quantitative

Spezifität: This assay has high sensitivity and excellent specificity for detection of Interleukin 35 (IL35)

Kreuzreaktivität (Details): No significant cross-reactivity or interference between Interleukin 35 (IL35) and analogues was observed.

Sensitivität: 5.8 pg/mL

Bestandteile:

• Pre-coated, ready to use 96-well strip plate, flat buttom
• Plate sealer for 96 wells
• Reference Standard
• Standard Diluent
• Detection Reagent A
• Detection Reagent B
• Assay Diluent A
• Assay Diluent B
• Reagent Diluent (if Detection Reagent is lyophilized)
• TMB Substrate
• Stop Solution
• Wash Buffer (30 x concentrate)
• Instruction manual

Anwendungsinformationen

Kommentare:

Information on standard material:
The standard might be recombinant protein or natural protein, that will depend on the specific kit. Moreover, the expression system is E.coli or yeast or mammal cell. There is 0.05% proclin 300 in the standard as preservative.

Information on reagents:
The stop solution used in the kit is sulfuric acid with concentration of 1 mol/L. And the wash solution is TBS. The standard diluent contains 0.02 % sodium azide, assay diluent A and assay diluent B contain 0.01% sodium azide. Some kits can contain is BSA in them.

Information on antibodies:
The provided antibodies and their host vary in different kits.

Probenmenge: 100 μL

Testdauer: 3 h

Plattentyp: Pre-coated

Protokoll:

1. Prepare all reagents, samples and standards,
2. Add 100μL standard or sample to each well. Incubate 1 hours at 37 °C,
3. Aspirate and add 100μL prepared Detection Reagent A. Incubate 1 hour at 37 °C,
4. Aspirate and wash 3 times,
5. Add 100μL prepared Detection Reagent B. Incubate 30 minutes at 37 °C,
6. Aspirate and wash 5 times,
7. Add 90μL Substrate Solution. Incubate 10-20 minutes at 37 °C,
8. Add 50μL Stop Solution. Read at 450nm immediately.

Aufbereitung der Reagenzien:

1. Bring all kit components and samples to room temperature (18-25 °C) before use. If the kit will not be used up in one time, please only take out strips and reagents for present experiment, and leave the remaining strips and reagents in required condition.
2. Standard - Reconstitute the Standard with 1.0 mL of Standard Diluent, keep for 10 minutes at room temperature, shake gently (not to foam). The concentration of the standard in the stock solution is 1,000pg/mL. Prepare 7 tubes containing 0.5 mL Standard Diluent and produce a double dilution series. Mix each tube thoroughly before the next transfer. Set up 7 points of diluted standard such as 1,000pg/mL, 500pg/mL, 250pg/mL, 125pg/mL, 62.5pg/mL, 31.2pg/mL, 15.6pg/mL, and the last microcentrifuge tube with Standard Diluent is the blank as 0pg/mL.
3. Detection Reagent A and Detection Reagent B - If lyophilized reconstitute the Detection Reagent A with 150μL of Reagent Diluent, keep for 10 minutes at room temperature, shake gently (not to foam). Briefly spin or centrifuge the stock Detection A and Detection B before use. Dilute them to the working concentration 100-fold with Assay Diluent A and B, respectively.
4. Wash Solution - Dilute 20 mL of Wash Solution concentrate (30x) with 580 mL of deionized or distilled water to prepare 600 mL of Wash Solution (1x).
5. TMB substrate - Aspirate the needed dosage of the solution with sterilized tips and do not dump the residual solution into the vial again.

Note:

1. Making serial dilution in the wells directly is not permitted.
2. Prepare standards within 15 minutes before assay. Please do not dissolve the reagents at 37 °C directly.
3. Please carefully reconstitute Standards or working Detection Reagent A and B according to the instruction, and avoid foaming and mix gently until the crystals are completely dissolved. To minimize imprecision caused by pipetting, use small volumes and ensure that pipettors are calibrated. It is recommended to suck more than 10μL for one pipetting.
4. The reconstituted Standards, Detection Reagent A and Detection Reagent B can be used only once.
5. If crystals have formed in the Wash Solution concentrate (30x), warm to room temperature and mix gently until the crystals are completely dissolved.
6. Contaminated water or container for reagent preparation will influence the detection result.

Aufbereitung der Proben:

• It is recommended to use fresh samples without long storage, otherwise protein degradation and denaturationmay occur in these samples, leading to false results. Samples should therefore be stored for a short periodat 2 - 8 °C or aliquoted at -20 °C (≤1 month) or -80 °C (≤ 3 months). Repeated freeze-thawcycles should be avoided. Prior to assay, the frozen samples should be slowly thawed and centrifuged toremove precipitates.
• If the sample type is not specified in the instructions, a preliminary test is necessary to determinecompatibility with the kit.
• If a lysis buffer is used to prepare tissue homogenates or cell culture supernatant, there is a possibilityof causing a deviation due to the introduced chemical substance.The recommended dilution factor is for reference only.
• Please estimate the concentration of the samples before performing the test. If the values are not in therange of the standard curve, the optimal sample dilution for the particular experiment has to be determined.Samples should then be diluted with PBS (pH =7.0-7.2).

Testpräzision: Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level of target were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level of target were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV < 10%
Inter-Assay: CV < 12%

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Vorsichtsmaßnahmen: The Stop Solution suggested for use with this kit is an acid solution. Wear eye, hand, face, and clothing protection when using this material.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung:

1. For unopened kit: All reagents should be stored according to the labels on the vials. The Standard, Detection Reagent A, Detection Reagent B, and 96-well Strip Plate should be stored at -20 °C upon receipt, while the other reagents should be stored at 4 °C.
2. For opened kits: the remaining reagents must be stored according to the above storage conditions. In addition, please return the unused wells to the foil pouch containing the desiccant and seal the foil pouch with the zipper.

.

Haltbarkeit: 6 months

Referenzen für Interleukin 35 ELISA Kit (ABIN6574300)

Zhu, Yang, Wang, Zhang, Guo: "Interleukin-35 is associated with the tumorigenesis and progression of prostate cancer." in: Oncology letters, Vol. 17, Issue 6, pp. 5094-5102, (2019) (PubMed).

Zhang, Peng, Ban, Zhang: "Upregulation of Interleukin 35 in Patients With Endometriosis Stimulates Cell Proliferation." in: Reproductive sciences (Thousand Oaks, Calif.), Vol. 25, Issue 3, pp. 443-451, (2018) (PubMed).

Lopez-Abente, Prieto-Sanchez, Muñoz-Fernandez, Correa-Rocha, Pion: "Human immunodeficiency virus type-1 induces a regulatory B cell-like phenotype in vitro." in: Cellular & molecular immunology, Vol. 15, Issue 10, pp. 917-933, (2018) (PubMed).

Kam, Liu, Cai, Mak, Wong, Chiu, Wong, Tsang, Tam: "Synoviocytes-derived Interleukin 35 Potentiates B Cell Response in Patients with Osteoarthritis and Rheumatoid Arthritis." in: The Journal of rheumatology, Vol. 45, Issue 4, pp. 563-573, (2018) (PubMed).

Li, Wang, Liu, Ding, Hao, Shao, Wang, Chen, Huang, Shao, Fu: "Lower level of IL‑35 and its reduced inhibition in Th17 cells in patients with bone marrow mononuclear cells Coombs test‑positive hemocytopenia." in: Molecular medicine reports, Vol. 17, Issue 2, pp. 2973-2981, (2018) (PubMed).

He, Liu, Liu: "Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients." in: The Tohoku journal of experimental medicine, Vol. 244, Issue 4, pp. 263-270, (2018) (PubMed).

Khoshkhui, Alyasin, Sarvestani, Amin, Ariaee: "Evaluation of serum interleukin- 35 level in children with persistent asthma." in: Asian Pacific journal of allergy and immunology, Vol. 35, Issue 2, pp. 91-95, (2017) (PubMed).

Zhou, Zhang, Chen, Wang, Hou: "Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy." in: OncoTargets and therapy, Vol. 10, pp. 3485-3491, (2017) (PubMed).

Jin, Liu, Lin: "IL-35 may maintain homeostasis of the immune microenvironment in periodontitis." in: Experimental and therapeutic medicine, Vol. 14, Issue 6, pp. 5605-5610, (2017) (PubMed).

Roccatello, Sciascia, Di Simone, Solfietti, Naretto, Fenoglio, Baldovino, Menegatti: "New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature." in: Autoimmunity reviews, Vol. 15, Issue 6, pp. 529-38, (2016) (PubMed).

Ringkowski, Loke, Huang, Ahmadzai, Herth, Thomas, Herbert: "Enhanced LPS-induced activation of IL-27 signalling in sarcoidosis." in: Respiratory medicine, Vol. 117, pp. 243-53, (2016) (PubMed).

Yin, Ge, Yang, Peng, Lu, Zhang, Wang: "The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis." in: Clinical rheumatology, Vol. 35, Issue 11, pp. 2715-2721, (2016) (PubMed).

Xiao, Wu, Yin, Han, Ding, Qiao, Lu, Deng, Bo, Gong: "Wogonin Inhibits Tumor-derived Regulatory Molecules by Suppressing STAT3 Signaling to Promote Tumor Immunity." in: Journal of immunotherapy (Hagerstown, Md. : 1997), Vol. 38, Issue 5, pp. 167-84, (2015) (PubMed).

Šenolt, Šumová, Jandová, Hulejová, Mann, Pavelka, Vencovský, Filková: "Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis." in: PLoS ONE, Vol. 10, Issue 7, pp. e0132674, (2015) (PubMed).

Tomcik, Zerr, Palumbo-Zerr, Storkanova, Hulejova, Spiritovic, Kodet, Stork, Becvar, Vencovsky, Pavelka, Filkova, Distler, Senolt: "Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease." in: Rheumatology (Oxford, England), Vol. 54, Issue 12, pp. 2273-82, (2015) (PubMed).

Yu, Ge, Lu, Shi, Li, Zhang, Wang, Huang, Shao, Huang, Zhang, Nie, Zheng: "Anti-inflammatory effects of interleukin-35 in acquired aplastic anemia." in: Cytokine, Vol. 76, Issue 2, pp. 409-16, (2015) (PubMed).

Sun, Zhang, Yang, Zhang, Lv, Fu, Lv, Liu, Chen, Liu, Huang, Xue, Liu, Zhang, Li, Yang: "Interleukin 35 may contribute to the loss of immunological self-tolerance in patients with primary immune thrombocytopenia." in: British journal of haematology, Vol. 169, Issue 2, pp. 278-85, (2015) (PubMed).

Sun, Kong, Liu, Yu, Tian, Ma, Ji: "The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia." in: Human immunology, Vol. 75, Issue 2, pp. 113-8, (2014) (PubMed).

Ozkan, Simsek, Ilhan, Deveci, Godekmerdan, Sapmaz: "Plasma IL-17, IL-35, interferon-?, SOCS3 and TGF-? levels in pregnant women with preeclampsia, and their relation with severity of disease." in: The journal of maternal-fetal & neonatal medicine, Vol. 27, Issue 15, pp. 1513-7, (2014) (PubMed).

Ozkan, Deveci, Kumbak, Simsek, Ilhan, Sekercioglu, Sapmaz: "What is the impact of Th1/Th2 ratio, SOCS3, IL17, and IL35 levels in unexplained infertility?" in: Journal of reproductive immunology, Vol. 103, pp. 53-8, (2014) (PubMed).

Details zu Interleukin 35

Target: Interleukin 35 (IL35)

Abstract: IL35 Produkte